Quick Takeaways
- VNRX - VOLITIONRX LTD has 23 insiders with reported activity on this page.
- Net insider value flow over the last year: +$294,916.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
Insider Transactions Reported by 23 Insiders of VOLITIONRX LTD
- Symbol
- VNRX on NYSE
- Location
- Henderson, NV
What Changed
- Buy value: $294,916; sell value: $0.
- Net share flow: +547,979.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to buying over the last 12 months. Net value: +$294,916.
Buys
$294,916
Shares: 547,979
Insiders: 4
Sells
$0
Shares: 0
Insiders: 0
Net
+$294,916
Shares: +547,979
Insiders: 4
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 20,000 | 0 | $7,000 | $0 | +$7,000 |
| 6-9 | 425,479 | 0 | $239,542 | $0 | +$239,542 |
| 9-12 | 102,500 | 0 | $48,374 | $0 | +$48,374 |
VOLITIONRX LTD executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Eight Corp Ltd | 10%+ Owner | $20,785,825 | Mixed | 02 Jan 2024 | ||
| Martin Charles Faulkes | Executive Director, Director | $1,739,852 | Mixed | 24 Jan 2024 | ||
| Cameron John Reynolds | President and CEO, Director | $1,039,334 | +$139,088 | +15% | Mixed | 26 Feb 2026 |
| Guy Archibald Innes | Director | $829,492 | +$109,810 | +15% | Mixed | 26 Feb 2026 |
| Timothy I. Still | Director | $415,467 | +$24,519 | +6.3% | Mixed | 22 Jan 2026 |
| Edward Futcher | Director | $362,242 | Mixed | 24 Jan 2024 | ||
| Rodney Gerard Rootsaert | Secretary | $307,610 | Mixed | 17 Mar 2026 | ||
| Terig Hughes | Chief Financial Officer | $171,242 | Mixed | 26 Feb 2026 | ||
| Gaetan Michel | Chief Operating Officer | $166,371 | Mixed | 04 Oct 2025 | ||
| Jacob Vincent Micallef | Chief Scientific Officer | $159,669 | +$21,500 | +16% | Mixed | 17 Mar 2026 |
| Jasmine Kway | CEO - Singapore Volition | $107,253 | Mixed | 26 Feb 2026 | ||
| Nicholas Plummer | GC - Volition Diagnostics | $97,744 | Mixed | 17 Mar 2026 | ||
| Salvatore Thomas Butera | CEO - Volition Veterinary | $95,901 | Mixed | 22 Jan 2026 | ||
| Gael Forterre | Chief Commercial Officer | $88,521 | Mixed | 17 Mar 2026 | ||
| Ann-Louise Batchelor | Group Chief Marketing Officer | $88,369 | Mixed | 26 Feb 2026 | ||
| Kim Nguyen | Director | $84,093 | Mixed | 26 Feb 2026 | ||
| Alan Colman | Director | $65,782 | Mixed | 22 Jan 2026 | ||
| Andrew Retter | Chief Medical Officer | $63,610 | Mixed | 01 Nov 2025 | ||
| Ethel Rubin | Director | $63,237 | Mixed | 26 Feb 2026 | ||
| Jason Bradley Terrell MD | Chief Medical Officer | $27,550 | Mixed | 03 Aug 2022 | ||
| Richard Brudnick | Director | $23,187 | Mixed | 12 Jan 2023 | ||
| Phillip Barnes | Director | $17,219 | Mixed | 22 Jan 2026 | ||
| Mickie Henshall | Director | $11,299 | Mixed | 22 Jan 2026 |
Top shareholders of VOLITIONRX LTD (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Eight Corp Ltd |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
24,030,664
mixed-class rows
|
$20,785,825 | — | 02 Jan 2024 | |
| Lagoda Investment Management, L.P. |
13D/G
13F
|
Company |
10%
|
12,535,706
|
$4,387,497 | +$290,747 | 31 Dec 2025 | |
| Martin Charles Faulkes |
3/4/5
|
Executive Director, Director |
—
class O/S missing
|
2,096,207
|
$1,739,852 | — | 24 Jan 2024 | |
| ARMISTICE CAPITAL, LLC |
13D/G
|
— |
5%
|
6,449,635
|
$1,612,409 | -$732,698 | 31 Dec 2025 | |
| Cameron John Reynolds |
3/4/5
|
President and CEO, Director |
—
mixed-class rows
|
4,267,341
mixed-class rows
|
$1,039,334 | +$139,088 | 26 Feb 2026 | |
| Guy Archibald Innes |
3/4/5
|
Director |
—
mixed-class rows
|
3,414,127
mixed-class rows
|
$829,492 | +$109,810 | 26 Feb 2026 | |
| Timothy I. Still |
3/4/5
|
Director |
—
mixed-class rows
|
1,673,534
mixed-class rows
|
$415,467 | +$24,519 | 22 Jan 2026 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
1,530,048
|
$391,692 | — | 31 Dec 2025 | |
| Edward Futcher |
3/4/5
|
Director |
—
class O/S missing
|
436,436
|
$362,242 | — | 24 Jan 2024 | |
| Rodney Gerard Rootsaert |
3/4/5
|
Secretary |
0.99%
|
1,281,711
|
$307,610 | — | 17 Mar 2026 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.75%
|
963,986
|
$246,436 | — | 31 Dec 2025 | |
| Terig Hughes |
3/4/5
|
Chief Financial Officer |
0.53%
|
684,970
|
$171,242 | — | 26 Feb 2026 | |
| Gaetan Michel |
3/4/5
|
Chief Operating Officer |
0.2%
|
256,746
|
$166,371 | — | 04 Oct 2025 | |
| Jacob Vincent Micallef |
3/4/5
|
Chief Scientific Officer |
0.51%
|
665,292
|
$159,669 | +$21,500 | 17 Mar 2026 | |
| BlackRock, Inc. |
13F
|
Company |
0.34%
|
445,187
|
$113,790 | — | 31 Dec 2025 | |
| Jasmine Kway |
3/4/5
|
CEO - Singapore Volition |
0.33%
|
429,014
|
$107,253 | — | 26 Feb 2026 | |
| Nicholas Plummer |
3/4/5
|
GC - Volition Diagnostics |
0.32%
|
407,267
|
$97,744 | — | 17 Mar 2026 | |
| Salvatore Thomas Butera |
3/4/5
|
CEO - Volition Veterinary |
0.29%
|
375,203
|
$95,901 | — | 22 Jan 2026 | |
| Gael Forterre |
3/4/5
|
Chief Commercial Officer |
0.29%
|
368,838
|
$88,521 | — | 17 Mar 2026 | |
| Ann-Louise Batchelor |
3/4/5
|
Group Chief Marketing Officer |
0.27%
|
353,478
|
$88,369 | — | 26 Feb 2026 | |
| Kim Nguyen |
3/4/5
|
Director |
0.26%
|
336,372
|
$84,093 | — | 26 Feb 2026 | |
| STATE STREET CORP |
13F
|
Company |
0.24%
|
311,538
|
$79,629 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.2%
|
259,593
|
$66,352 | — | 31 Dec 2025 | |
| Alan Colman |
3/4/5
|
Director |
—
mixed-class rows
|
282,364
mixed-class rows
|
$65,782 | — | 22 Jan 2026 | |
| Silverberg Bernstein Capital Management LLC |
13F
|
Company |
0.19%
|
249,282
|
$63,716 | — | 31 Dec 2025 | |
| Andrew Retter |
3/4/5
|
Chief Medical Officer |
0.11%
|
146,568
|
$63,610 | — | 01 Nov 2025 | |
| Ethel Rubin |
3/4/5
|
Director |
0.2%
|
252,948
|
$63,237 | — | 26 Feb 2026 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.13%
|
167,730
|
$42,872 | — | 31 Dec 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.1%
|
134,668
|
$34,421 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.09%
|
111,419
|
$28,479 | — | 31 Dec 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.08%
|
108,581
|
$28,000 | — | 31 Dec 2025 | |
| Jason Bradley Terrell MD |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
33,192
|
$27,550 | — | 03 Aug 2022 | |
| Richard Brudnick |
3/4/5
|
Director |
—
class O/S missing
|
27,936
|
$23,187 | — | 12 Jan 2023 | |
| Warberg Asset Management LLC |
13F
|
Company |
0.07%
|
90,833
|
$23,162 | — | 31 Dec 2025 | |
| Phillip Barnes |
3/4/5
|
Director |
0.05%
|
67,368
|
$17,219 | — | 22 Jan 2026 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
56,834
|
$14,527 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
55,596
|
$14,210 | — | 31 Dec 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.04%
|
50,000
|
$12,780 | — | 31 Dec 2025 | |
| Mickie Henshall |
3/4/5
|
Director |
0.03%
|
44,206
|
$11,299 | — | 22 Jan 2026 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.03%
|
39,999
|
$10,224 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
25,300
|
$6,467 | — | 31 Dec 2025 | |
| Cetera Investment Advisers |
13F
|
Company |
0.02%
|
20,550
|
$5,253 | — | 31 Dec 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
15,956
|
$4,078 | — | 31 Dec 2025 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.01%
|
14,595
|
$3,730 | — | 31 Dec 2025 | |
| Chicago Partners Investment Group LLC |
13F
|
Company |
0.01%
|
11,999
|
$3,384 | — | 31 Dec 2025 | |
| Creative Planning |
13F
|
Company |
0.01%
|
12,834
|
$3,280 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
960
|
$245 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
665
|
$170 | — | 31 Dec 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
430
|
$110 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
310
|
$79 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for VOLITIONRX LTD
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Gael Forterre | VNRX | Common Stock | Tax liability | -1.56% | -5,251 | 331,338 | 17 Mar 2026 | Direct | ||
| Rodney Gerard Rootsaert | VNRX | Common Stock | Tax liability | -1.42% | -3,948 | 273,993 | 17 Mar 2026 | Direct | ||
| Jacob Vincent Micallef | VNRX | Common Stock | Tax liability | -0.92% | -5,310 | 572,179 | 17 Mar 2026 | Direct | ||
| Nicholas Plummer | VNRX | Common Stock | Tax liability | -1.69% | -7,003 | 407,267 | 17 Mar 2026 | Direct | ||
| Rodney Gerard Rootsaert | VNRX | Common Stock | Tax liability | -1.18% | -3,321 | 277,941 | 01 Mar 2026 | Direct | ||
| Gael Forterre | VNRX | Common Stock | Tax liability | -0.67% | -2,283 | 336,589 | 01 Mar 2026 | Direct | ||
| Nicholas Plummer | VNRX | Common Stock | Tax liability | -1.4% | -5,867 | 414,270 | 01 Mar 2026 | Direct | ||
| Gael Forterre | VNRX | Common Stock | Award | 78.5% | 149,000 | 338,872 | 26 Feb 2026 | Direct | ||
| Ethel Rubin | VNRX | Common Stock | Award | 237.5% | 178,000 | 252,948 | 26 Feb 2026 | Direct | ||
| Cameron John Reynolds | VNRX | Common Stock | Award | 18.5% | 486,000 | 3,115,547 | 26 Feb 2026 | Direct | ||
| Ann-Louise Batchelor | VNRX | Common Stock | Award | 78% | 142,000 | 324,072 | 26 Feb 2026 | Direct | ||
| Terig Hughes | VNRX | Common Stock | Award | 41.8% | 202,000 | 684,970 | 26 Feb 2026 | Direct | ||
| Rodney Gerard Rootsaert | VNRX | Common Stock | Award | 73.3% | 119,000 | 281,262 | 26 Feb 2026 | Direct | ||
| Nicholas Plummer | VNRX | Common Stock | Award | 80.2% | 187,000 | 420,137 | 26 Feb 2026 | Direct | ||
| Kim Nguyen | VNRX | Common Stock | Award | 139.3% | 178,000 | 305,816 | 26 Feb 2026 | Direct | ||
| Jasmine Kway | VNRX | Common Stock | Award | 70.4% | 173,000 | 418,614 | 26 Feb 2026 | Direct | ||
| Jacob Vincent Micallef | VNRX | Common Stock | Award | 34.8% | 149,000 | 577,489 | 26 Feb 2026 | Direct | ||
| Guy Archibald Innes | VNRX | Common Stock | Award | 16.6% | 178,000 | 1,252,967 | 26 Feb 2026 | Direct | ||
| Nicholas Plummer | VNRX | Common Stock | Tax liability | -2.36% | -5,647 | 233,137 | 01 Feb 2026 | Direct | ||
| Gael Forterre | VNRX | Common Stock | Tax liability | -1.05% | -2,010 | 189,872 | 01 Feb 2026 | Direct | ||
| Rodney Gerard Rootsaert | VNRX | Common Stock | Tax liability | -1.93% | -3,196 | 162,262 | 01 Feb 2026 | Direct | ||
| Ethel Rubin | VNRX | Common Stock | Award | 19.1% | 12,000 | 74,948 | 22 Jan 2026 | Direct | ||
| Ann-Louise Batchelor | VNRX | Common Stock | Award | 22.9% | 33,900 | 182,072 | 22 Jan 2026 | Direct | ||
| Mickie Henshall | VNRX | Common Stock | Award | 37.3% | 12,000 | 44,206 | 22 Jan 2026 | Direct | ||
| Nicholas Plummer | VNRX | Common Stock | Award | 23% | 44,700 | 238,784 | 22 Jan 2026 | Direct | ||
| Kim Nguyen | VNRX | Common Stock | Award | 10.4% | 12,000 | 127,816 | 22 Jan 2026 | Direct | ||
| Gael Forterre | VNRX | Common Stock | Award | 24.8% | 38,100 | 191,882 | 22 Jan 2026 | Direct | ||
| Terig Hughes | VNRX | Common Stock | Award | 11.3% | 49,200 | 482,970 | 22 Jan 2026 | Direct | ||
| Salvatore Thomas Butera | VNRX | Common Stock | Award | 16.6% | 53,400 | 375,203 | 22 Jan 2026 | Direct | ||
| Jasmine Kway | VNRX | Common Stock | Award | 20.6% | 42,000 | 245,614 | 22 Jan 2026 | Direct | ||
| Phillip Barnes | VNRX | Common Stock | Award | 21.7% | 12,000 | 67,368 | 22 Jan 2026 | Direct | ||
| Jacob Vincent Micallef | VNRX | Common Stock | Award | 9.01% | 35,400 | 428,489 | 22 Jan 2026 | Direct | ||
| Guy Archibald Innes | VNRX | Common Stock | Award | 1.13% | 12,000 | 1,074,967 | 22 Jan 2026 | Direct | ||
| Rodney Gerard Rootsaert | VNRX | Common Stock | Award | 20.6% | 28,200 | 165,458 | 22 Jan 2026 | Direct | ||
| Alan Colman | VNRX | Common Stock | Award | 4.89% | 12,000 | 257,364 | 22 Jan 2026 | Direct | ||
| Cameron John Reynolds | VNRX | Common Stock | Award | 2.92% | 74,700 | 2,629,547 | 22 Jan 2026 | Direct | ||
| Timothy I. Still | VNRX | Common Stock | Award | 5.86% | 90,000 | 1,625,458 | 22 Jan 2026 | Direct | ||
| Cameron John Reynolds | VNRX | Common Stock | Purchase | 0.79% | $7,000 | $0.3500 | 20,000 | 2,554,847 | 17 Nov 2025 | Direct |
| Andrew Retter | VNRX | Common Stock | Tax liability | -3.04% | -4,588 | 146,568 | 01 Nov 2025 | Direct | ||
| Nicholas Plummer | VNRX | Common Stock | Tax liability | -2.83% | -5,647 | 194,084 | 01 Nov 2025 | Direct | ||
| Gael Forterre | VNRX | Common Stock | Tax liability | -1.13% | -1,753 | 153,782 | 01 Nov 2025 | Direct | ||
| Salvatore Thomas Butera | VNRX | Common Stock | Tax liability | -1.42% | -4,648 | 321,803 | 01 Nov 2025 | Direct | ||
| Rodney Gerard Rootsaert | VNRX | Common Stock | Tax liability | -2.28% | -3,197 | 137,258 | 01 Nov 2025 | Direct | ||
| Cameron John Reynolds | VNRX | Common Stock | Purchase | 4.54% | $56,100 | $0.5100 | 110,000 | 2,534,847 | 14 Oct 2025 | Direct |
| Cameron John Reynolds | VNRX | Warrant (Right to Buy) | Purchase | 110,000 | 110,000 | 14 Oct 2025 | Direct | |||
| Guy Archibald Innes | VNRX | Common Stock | Purchase | 9.95% | $49,038 | $0.5100 | 96,153 | 1,062,967 | 14 Oct 2025 | Direct |
| Guy Archibald Innes | VNRX | Warrant (Right to Buy) | Purchase | 96,153 | 96,153 | 14 Oct 2025 | Direct | |||
| Timothy I. Still | VNRX | Common Stock | Purchase | 3.23% | $24,519 | $0.5100 | 48,076 | 1,535,458 | 14 Oct 2025 | Direct |
| Timothy I. Still | VNRX | Warrant (Right to Buy) | Purchase | 48,076 | 48,076 | 14 Oct 2025 | Direct | |||
| Ann-Louise Batchelor | VNRX | Common Stock | Tax liability | -3.96% | -6,110 | 148,172 | 04 Oct 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.